Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,606 | 3 | 53.5% |
| Food and Beverage | $1,396 | 31 | 46.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $1,822 | 6 | $0 (2018) |
| PFIZER INC. | $372.95 | 7 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $129.24 | 2 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $124.46 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $97.36 | 2 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $92.98 | 4 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $87.91 | 1 | $0 (2018) |
| Gilead Sciences Inc | $87.91 | 4 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $82.15 | 1 | $0 (2019) |
| Lantheus Medical Imaging, Inc. | $71.85 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.82 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($13.82) |
| 2023 | $27.45 | 2 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($14.68) |
| 2022 | $112.06 | 5 | SANOFI-AVENTIS U.S. LLC ($71.00) |
| 2021 | $21.98 | 1 | SANOFI-AVENTIS U.S. LLC ($21.98) |
| 2020 | $177.82 | 4 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($75.66) |
| 2019 | $310.71 | 4 | PFIZER INC. ($228.56) |
| 2018 | $494.58 | 7 | Novartis Pharmaceuticals Corporation ($108.48) |
| 2017 | $1,843 | 10 | BOSTON SCIENTIFIC CORPORATION ($1,724) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.82 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/23/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.68 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/10/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $12.77 | General |
| Category: Cardiovascular Device | ||||||
| 12/20/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/15/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/26/2021 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/12/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $75.66 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/11/2020 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $71.85 | General |
| Category: CONTRAST AGENT | ||||||
| 03/11/2020 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/06/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: Cardiovascular | ||||||
| 12/16/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $102.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/23/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $82.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/29/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $112.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2018 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $78.24 | General |
| Category: STRUCTURAL HEART | ||||||
| 12/13/2018 | BOSTON SCIENTIFIC CORPORATION | EMBLEM (Device) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: TACHY | ||||||
| 09/19/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Cardiology | ||||||
| 07/11/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $78.91 | General |
| Category: Cardiovascular | ||||||
| 04/17/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $101.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/27/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $87.91 | General |
| 02/22/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $108.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/28/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $26.46 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 973 | 1,129 | $196,382 | $64,369 |
| 2022 | 21 | 1,118 | 1,269 | $204,713 | $71,881 |
| 2021 | 18 | 1,087 | 1,185 | $191,152 | $71,028 |
| 2020 | 21 | 990 | 1,106 | $166,273 | $54,553 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 153 | $43,299 | $13,677 | 31.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 89 | 133 | $29,925 | $12,147 | 40.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 200 | 200 | $31,510 | $9,919 | 31.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 64 | 65 | $28,392 | $8,182 | 28.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 63 | 63 | $9,765 | $2,804 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $7,770 | $2,409 | 31.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $6,831 | $2,256 | 33.0% |
| 99236 | Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | Facility | 2023 | 13 | 13 | $6,058 | $2,113 | 34.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 35 | 35 | $6,020 | $2,011 | 33.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 26 | 26 | $4,472 | $1,538 | 34.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 20 | 20 | $4,800 | $1,531 | 31.9% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 12 | 14 | $3,360 | $1,101 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,458 | $1,080 | 31.2% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 11 | 11 | $2,805 | $936.82 | 33.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 42 | 45 | $2,520 | $829.90 | 32.9% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 27 | 54 | $1,350 | $425.28 | 31.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 36 | 36 | $1,152 | $379.05 | 32.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 26 | 26 | $832.00 | $281.58 | 33.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 29 | 62 | $620.00 | $260.40 | 42.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 25 | 31 | $558.00 | $183.57 | 32.9% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 33 | 33 | $528.00 | $183.15 | 34.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 50 | 51 | $357.00 | $121.38 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 179 | $40,729 | $14,489 | 35.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 78 | 79 | $32,275 | $11,775 | 36.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 229 | 232 | $34,546 | $11,720 | 33.9% |
About Dr. Christopher Spizzieri, D.O
Dr. Christopher Spizzieri, D.O is a Cardiovascular Disease healthcare provider based in Camp Hill, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992708010.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Spizzieri, D.O has received a total of $3,002 in payments from pharmaceutical and medical device companies, with $13.82 received in 2024. These payments were reported across 34 transactions from 12 companies. The most common payment nature is "Travel and Lodging" ($1,606).
As a Medicare-enrolled provider, Spizzieri has provided services to 4,168 Medicare beneficiaries, totaling 4,689 services with total Medicare billing of $261,831. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Camp Hill, PA
- Active Since 05/23/2005
- Last Updated 06/10/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1992708010
Products in Payments
- WATCHMAN (Device) $1,684
- ELIQUIS (Drug) $342.84
- ENTRESTO (Drug) $129.24
- VYNDAQEL (Drug) $127.47
- LifeVest (Device) $124.46
- WATCHMAN DEVICE (Device) $117.80
- MULTAQ (Drug) $92.98
- XARELTO (Drug) $82.15
- DEFINITY (Drug) $71.85
- Repatha (Biological) $20.25
- EMBLEM (Device) $19.68
- OPTIMIZER (Device) $12.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Camp Hill
Dr. Frank Bowen, Md, MD
Cardiovascular Disease — Payments: $698,274
Venkatesh Nadar, Md, MD
Cardiovascular Disease — Payments: $110,037
Dr. David Man, M.d, M.D
Cardiovascular Disease — Payments: $67,970
Dr. Andreas Wali, M.d, M.D
Cardiovascular Disease — Payments: $9,944
Safwat Gassis, M.d, M.D
Cardiovascular Disease — Payments: $6,554
Dr. Lenke Erki, M.d, M.D
Cardiovascular Disease — Payments: $1,871